Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.81 and traded as high as $6.4329. Predictive Oncology shares last traded at $5.60, with a volume of 381,133 shares changing hands.
Predictive Oncology Stock Performance
The firm has a market cap of $19.01 million, a P/E ratio of -0.41 and a beta of 1.35. The firm’s fifty day moving average price is $3.80 and its 200 day moving average price is $4.81.
About Predictive Oncology
Predictive Oncology, Inc is a biotechnology company that leverages artificial intelligence and digital biology to support drug discovery and development in oncology. Its core business revolves around the application of machine learning algorithms to high-content cellular imaging, multi-omic profiling, and clinical response data. By integrating these diverse data streams, the company aims to generate predictive models that forecast the efficacy and toxicity of candidate therapeutics, thereby accelerating preclinical decision-making and reducing development timelines.
The company’s primary offerings include its Phenomics platform, which combines automated microscopy with advanced image analysis to capture subtle phenotypic changes in cancer cells.
Further Reading
- Five stocks we like better than Predictive Oncology
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
